Avalere Health Insights Who We Help Expertise About Us Submit Connect Rely on Our Robust Real-World Data Utilization Management Trends in the Commercial Market, 2014–2020 State Policy Exchange Operational Models for 2022 Drug Pricing Part B Drug Negotiation Under BBBA Would Reduce Payments to Providers Quality Improvement Survey Shows Potential, Challenges, and Solutions for Broad PDT Access Social Determinants of Health Universal Pre-K Could Affect Access to Preventive and Diagnostic Care Vaccines / Preventive Services Webinar: Driving Vaccine Access and Uptake Federal Policy More Medicare Advantage Plans Will Offer Non-Medical Benefits in 2022 Social Determinants of Health Disparities in Medicare Mortality Rates Occurred During the Pandemic “COVID-19 vaccine issues show the need for an immunization registry system.” Kevin Kissling Senior Consultant 0M individuals who may benefit from expanded exchange coverage subsidies Federal Policy Video: Medicare Part D, Part V: What's Next for CMMI? “Each company’s return-to-work plan will be based on a unique subset of characteristics.” Emily Belowich Consultant I 0% of covered generic products now placed on non-generic Part D tiers Value-Based Care Video: Cell and Gene Therapy in Oncology, Part II Avalere Health An Inovalon Company 1201 New York Avenue NW Suite 1000 Washington, DC 20005 Phone 202.207.1300 Fax 202.467.4455 info@avalere.com Contact Careers Privacy Policy Terms of Use Twitter LinkedIn Avalere is a healthcare consulting firm dedicated to improving healthcare. Our life sciences, plan, and provider clients count on us to help them anticipate and adapt to the latest industry trends. © 2021 - Avalere Health We'll assume you're ok with this, but you can opt-out if you wish.Accept